RAPIvD was established in 2018 by Dr Robert Porter to provide world-class contract research, development and manufacturing services to the fast-growing in vitro diagnostics (IVD) sector.

​

Rob's first project (in the mid 1980’s) was to assist with the development of the first ‘at home’ lateral flow test, Clearblue. This followed his father’s patented technique of using paired monoclonal antibodies to bind to antigens. With more than 30 years of experience in this specialist field, Rob has the knowledge and network to provide customers with new and better lateral flow and other IVD devices.

The covid-19 pandemic demonstrated the value of large-scale, low-cost, convenient and accurate point-of-care diagnostic tests. The increased awareness of the technology accelerated the growing interest in its capabilities. 

 

RAPIvD has a team of dedicated scientists and high quality laboratory and manufacturing facilities at its headquarters in Colworth, Bedfordshire, UK. 

 

The company is ISO 13485 certified.